Hairy Cell Leukemia Patient Data Registry
Launched by OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER · Sep 24, 2015
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The Hairy Cell Leukemia Patient Data Registry is a study aimed at gathering important information about hairy cell leukemia, a rare type of blood cancer that affects adults. With around 1,000 new cases diagnosed in the U.S. each year, this registry will help researchers better understand the disease, find out which treatments work best, identify any new complications, and design future clinical trials for new therapies. By collecting data from patients, the goal is to ultimately improve the quality of life for those living with this condition.
To participate in this study, patients must be adults diagnosed with either classic hairy cell leukemia or its variant. Unfortunately, children cannot participate since this disease typically doesn’t occur in younger individuals. Those who join the registry can expect to provide information about their health and experiences, which will be used to help advance research and improve care for future patients. This project is currently recruiting participants, and anyone interested should talk to their healthcare provider about eligibility and how they can get involved.
Gender
ALL
Eligibility criteria
- Inclusion:
- • Patients with classic hairy cell leukemia
- • Patients with the variant of hairy cell leukemia.
- Exclusion:
- • Children are excluded from the study, since Hairy Cell Leukemia wasn't described in children.
About Ohio State University Comprehensive Cancer Center
The Ohio State University Comprehensive Cancer Center (OSUCCC) is a leading institution dedicated to advancing cancer research, treatment, and education. As a National Cancer Institute-designated comprehensive cancer center, OSUCCC integrates cutting-edge research with clinical practice to develop innovative therapies and improve patient outcomes. With a collaborative approach that unites scientists and clinicians, OSUCCC focuses on personalized medicine, cancer prevention, and community outreach, striving to enhance the understanding of cancer biology and provide hope to patients through groundbreaking clinical trials and comprehensive care programs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Columbus, Ohio, United States
Winnipeg, Manitoba, Canada
Miami, Florida, United States
Rochester, New York, United States
Melbourne, Victoria, Australia
Patients applied
Trial Officials
Michael Grever, MD
Principal Investigator
The Ohio State University Comprehensive Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials